Latest filing published 14 Aug 2025 for IGM Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Michael Stewart Lee across 2 companies, led by IGM Biosciences, Inc. and Fate Therapeutics Inc. Over a trading history stretching from 2 June 2021 to 14 August 2025, the count stands at 20 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 14 August 2025 came the latest disclosure, a transaction in IGM Biosciences, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations